Y-Mabs Therapeutics Inc (NQ: YMAB )
6.160 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Press Releases about Y-Mabs Therapeutics Inc
Y-MABS THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. - YMAB
January 24, 2023
ROSEN, A TOP RANKED LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 22, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.